Clinical trial
A phase III multicenter, randomized study of oral LDK378 versus standard chemotherapy in previously untreated adult patients with ALK rearranged (ALK-positive), stage IIIB or IV, non-squamous non-small cell lung cancer
To compare the antitumor activity of LDK378 versus reference chemotherapy, as measured by PFS determined by a BIRC
| Category | Value |
|---|---|
| Study start date | 2013-06-07 |